Conference Coverage

At 2 Years, Resolute Stent Performs Well in Diabetes Patients

Publish date: May 31, 2012

 

FROM THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS

The post hoc analysis was funded by Medtronic, and Dr. Lee is an employee of the company. Dr. Garber is a consultant/advisory board member and/or on the speakers bureaus for Novo Nordisk, Daiichi Sankyo, Merck, Takeda, LipoScience, Boehringer Ingelheim, Sekris, and Lexicon.

Pages

Recommended Reading

Access to Personal Health Metrics Called a 'Civil Right'
MDedge Internal Medicine
Women's Stroke Risk Higher in AF, Regardless of Warfarin Use
MDedge Internal Medicine
Athletes With ICDs Have a Sporting Chance for Safe Play
MDedge Internal Medicine
Warfarin Self-Testing Boosts Time in Therapeutic Range
MDedge Internal Medicine
Coronary Dissection Drives MI Rates in Pregnancy
MDedge Internal Medicine
Fingolimod Label Advises ECG Monitoring at First Dose
MDedge Internal Medicine
ACC Urges Shift to Patient-Centered Care
MDedge Internal Medicine
Ablation Safe, Effective for First-Line Atrial Fib Treatment
MDedge Internal Medicine
Azithromycin Slightly Raises Risk of Cardiovascular Death
MDedge Internal Medicine
Longer ICD Detection Window Reduces Inappropriate Shocks
MDedge Internal Medicine